[Form 3] MEI Pharma, Inc. Initial Statement of Beneficial Ownership
Alexander Schornstein filed a Form 3 disclosing initial beneficial ownership in Lite Strategy, Inc. (MEIP). The filing reports ownership of 4,365,472 shares of Common Stock, of which 4,140,472 are held directly by Mr. Schornstein and 225,000 are held by Camino Capital GmbH, an entity of which he is the sole beneficial owner and holds sole voting power.
The filing indicates a reporting relationship to the issuer as a director and was dated as the event on 09/09/2025 with a signature dated 09/10/2025. No derivative securities or exercise terms were reported.
- Clear disclosure of both direct and indirect holdings, including the split between personal holdings and those held through Camino Capital GmbH
- No derivative securities reported, indicating no immediate dilution from options, warrants, or convertible instruments disclosed on this Form 3
- None.
Insights
TL;DR: Director disclosed meaningful direct and indirect stock ownership, consolidating voting control through a private entity.
The Form 3 shows Mr. Schornstein holds a combined 4,365,472 common shares, including 225,000 held via Camino Capital GmbH where he is sole beneficial owner and sole voting power. This structure centralizes voting influence and aligns director interests with shareholders. The filing contains no derivative positions and no amendments. From a governance perspective, clear disclosure of indirect holdings and voting power is standard and helps market transparency.
TL;DR: Initial ownership disclosure is neutral operationally but relevant for shareholding composition.
The Form 3 is an administrative disclosure of beneficial ownership rather than an operational development. It confirms a director-level insider has a notable equity stake of 4,365,472 shares. There are no reported transactions, option grants, or convertible instruments in this filing, so immediate financial impact or dilution is not indicated. Investors gain clarity on insider stake and voting alignment.